Roche drug keeps patients cancer-free longer

ZURICH (Reuters) – Roche’s cancer drug Xeloda enabled elderly patients being treated for colorectal cancer to live free of the disease for longer, the world’s largest maker of cancer drugs said on Thursday.
A study showed that patients above the age of 65 or 70 years who took Xeloda, or capecitabine, with Xelox, or oxaliplatin, immediately [...]